CORCEPT THERAPEUTICS INC Other Nonoperating Expense
CORCEPT THERAPEUTICS INC (CORT) reported Other Nonoperating Expense of $5.00 thousand for the 3-month period ending 2012-06-30, per its 10-Q filed 2012-08-09.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingExpense · last filed 2012-08-09
- CORCEPT THERAPEUTICS INC other nonoperating expense for the quarter ending 2012-06-30 was $5.00K, a 58.33% decline year-over-year.
- CORCEPT THERAPEUTICS INC other nonoperating expense for the quarter ending 2012-03-31 was $5.00K, a 0.00% change year-over-year.
- CORCEPT THERAPEUTICS INC other nonoperating expense for the quarter ending 2011-12-31 was $8.00K, a 14.29% increase year-over-year.
- CORCEPT THERAPEUTICS INC other nonoperating expense for the quarter ending 2011-09-30 was $1.00K, a 66.67% decline year-over-year.
- CORCEPT THERAPEUTICS INC other nonoperating expense for fiscal 2011 was $25.00K, a 0.00% change from fiscal 2010.
- CORCEPT THERAPEUTICS INC other nonoperating expense for fiscal 2010 was $25.00K, a 47.06% increase from fiscal 2009.
- CORCEPT THERAPEUTICS INC other nonoperating expense for fiscal 2009 was $17.00K.
| Period end | Other Nonoperating Expense 3 month | Other Nonoperating Expense 6 month | Other Nonoperating Expense 9 month | Other Nonoperating Expense 12 month | Other Nonoperating Expense 158 month | Other Nonoperating Expense 161 month | Other Nonoperating Expense 164 month | Other Nonoperating Expense 167 month |
|---|---|---|---|---|---|---|---|---|
| 2012-06-30 | $5.00K 10-Q · filed 2012-08-09 | $9.00K 10-Q · filed 2012-08-09 | $18.00K derived: sum of 3 quarters · filed 2012-08-09 | $19.00K derived: sum of 4 quarters · filed 2012-08-09 | ||||
| 2012-03-31 | $5.00K 10-Q · filed 2012-05-10 | $13.00K derived: sum of 2 quarters · filed 2012-05-10 | $14.00K derived: sum of 3 quarters · filed 2012-05-10 | $26.00K derived: sum of 4 quarters · filed 2012-08-09 | $1.66M 10-Q · filed 2012-05-10 | |||
| 2011-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-13 | $9.00K derived: sum of 2 quarters · filed 2012-03-13 | $21.00K derived: sum of 3 quarters · filed 2012-08-09 | $25.00K 10-K · filed 2012-03-13 | $1.66M 10-K · filed 2012-03-13 | |||
| 2011-09-30 | $1.00K 10-Q · filed 2011-11-08 | $13.00K derived: sum of 2 quarters · filed 2012-08-09 | $17.00K 10-Q · filed 2011-11-08 | $25.00K derived: sum of 4 quarters · filed 2012-08-09 | $1.65M 10-Q · filed 2011-11-08 | |||
| 2011-06-30 | $12.00K 10-Q · filed 2012-08-09 | $17.00K 10-Q · filed 2012-08-09 | $24.00K derived: sum of 3 quarters · filed 2012-08-09 | $27.00K derived: sum of 4 quarters · filed 2012-08-09 | $1.65M 10-Q · filed 2011-08-09 | |||
| 2011-03-31 | $5.00K 10-Q · filed 2012-05-10 | $12.00K derived: sum of 2 quarters · filed 2012-05-10 | $15.00K derived: sum of 3 quarters · filed 2012-05-10 | $18.00K derived: sum of 4 quarters · filed 2012-05-10 | ||||
| 2010-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-13 | $10.00K derived: sum of 2 quarters · filed 2012-03-13 | $13.00K derived: sum of 3 quarters · filed 2012-03-13 | $25.00K 10-K · filed 2012-03-13 | ||||
| 2010-09-30 | $3.00K 10-Q · filed 2011-11-08 | $6.00K derived: sum of 2 quarters · filed 2011-11-08 | $18.00K 10-Q · filed 2011-11-08 | |||||
| 2010-06-30 | $3.00K 10-Q · filed 2011-08-09 | $14.00K 10-Q · filed 2011-08-09 | ||||||
| 2009-12-31 | $17.00K 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |